Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis
10.1038/78475
Crossref journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
Bibliography

Zhang, H., Cook, J., Nickel, J., Yu, R., Stecker, K., Myers, K., & Dean, N. M. (2000). Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nature Biotechnology, 18(8), 862–867.

Authors 7
  1. Hong Zhang (first)
  2. Jesse Cook (additional)
  3. Jeffrey Nickel (additional)
  4. Rosie Yu (additional)
  5. Kimberly Stecker (additional)
  6. Kathleen Myers (additional)
  7. Nicholas M. Dean (additional)
References 48 Referenced 210
  1. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1455 (1995). (10.1126/science.7533326) / Science by S Nagata (1995)
  2. Nagata, S. Apoptosis mediated by the Fas system. Prog. Mol. Subcell. Biol. 16, 87–103 (1996). (10.1007/978-3-642-79850-4_6) / Prog. Mol. Subcell. Biol. by S Nagata (1996)
  3. Galle, P.R. & Krammer, P.H. CD95-induced apoptosis in human liver disease. Semin. Liver Dis. 18, 141–151 (1998). (10.1055/s-2007-1007150) / Semin. Liver Dis. by PR Galle (1998)
  4. Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the fas ligand in the development of hepatitis. Nat. Med. 3, 409–413 (1997). (10.1038/nm0497-409) / Nat. Med. by T Kondo (1997)
  5. Kuwano, K. et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104, 13–19 (1999). (10.1172/JCI5628) / J. Clin. Invest. by K Kuwano (1999)
  6. Viard, I. et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490–493 (1998). (10.1126/science.282.5388.490) / Science by I Viard (1998)
  7. Dittel, B.N., Merchant, R.M. & Janeway, C.A.J. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162, 6392–6400 (1999). (10.4049/jimmunol.162.11.6392) / J. Immunol. by BN Dittel (1999)
  8. Strater, J. et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113, 160–167 (1997). (10.1016/S0016-5085(97)70091-X) / Gastroenterology by J Strater (1997)
  9. Kong, L. et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40, 87–97 (1997). (10.1002/art.1780400113) / Arthritis Rheum. by L Kong (1997)
  10. Giordano, C. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960–963 (1997). (10.1126/science.275.5302.960) / Science by C Giordano (1997)
  11. Stassi, G. et al. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J. Immunol. 162, 263–267 (1999). (10.4049/jimmunol.162.1.263) / J. Immunol. by G Stassi (1999)
  12. Josien, R. et al. Fas ligand, tumor necrosis facter-a expression, and apoptosis during allograft rejection and tolerance. Transplantation 66, 887–893 (1998). (10.1097/00007890-199810150-00013) / Transplantation by R Josien (1998)
  13. Rudi, J. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Invest. 102, 1506–1514 (1998). (10.1172/JCI2808) / J. Clin. Invest. by J Rudi (1998)
  14. Miwa, K. et al. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int. Immunol. 11, 925–931 (1999). (10.1093/intimm/11.6.925) / Int. Immunol. by K Miwa (1999)
  15. Cooper, S.R., Taylor, J.K., Miraglia, L.J. & Dean, N.M. Pharmacology of antisense oligonucleotide inhibitors of protein expression. Pharmacol. Ther. 82, 427–435 (1999). (10.1016/S0163-7258(99)00002-9) / Pharmacol. Ther. by SR Cooper (1999)
  16. Crooke, S.T. Basic principles of antisense therapeutics. In Antisense research and application. (ed. Crooke, S.T.) 1–50 (Springer-Verlag, Berlin; 1998). (10.1007/978-3-642-58785-6) / Antisense research and application by ST Crooke (1998)
  17. Taylor, J.K., Zhang, Q.Q., Wyatt, J.R. & Dean, N.M. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 17, 1097–1100 (1999). (10.1038/15079) / Nat. Biotechnol. by JK Taylor (1999)
  18. Kole, R. Modification of pre-mRNA splicing by antisense oligonucleotides. Acta Biochimica Polonica 44, 231–238 (1997). (10.18388/abp.1997_4418) / Acta Biochimica Polonica by R Kole (1997)
  19. Dean, N.M., McKay, R., Condon, T.P. & Bennett, C.F. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269, 16416–16424 (1994). (10.1016/S0021-9258(17)34023-1) / J. Biol. Chem. by NM Dean (1994)
  20. Zhang, H. et al. Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV–vaccinia virus recombinant. Antimicrob. Agents Chemother. 43, 347–353 (1999). (10.1128/AAC.43.2.347) / Antimicrob. Agents Chemother. by H Zhang (1999)
  21. Mizuta, T. et al. Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A. Nat. Biotechnol. 17, 583–587 (1999). (10.1038/9893) / Nat. Biotechnol. by T Mizuta (1999)
  22. Bennett, C.F. et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp. Ther. 280, 988–1000 (1997). / J. Pharmacol. Exp. Ther. by CF Bennett (1997)
  23. Noiri, E., Peresleni, T., Miller, F. & Goligorsky, M.S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97, 2377–2383 (1996). (10.1172/JCI118681) / J. Clin. Invest. by E Noiri (1996)
  24. Driver, S.E. et al. Oligonucleotide-based inhibition of embryonic gene expression. Nat. Biotechnol. 17, 1184–1187 (1999). (10.1038/70724) / Nat. Biotechnol. by SE Driver (1999)
  25. Crooke, S.T. Molecular mechanisms of antisense drugs: RNase H. Antisense Nucleic Acid Drug Dev. 8, 133–134 (1998). (10.1089/oli.1.1998.8.133) / Antisense Nucleic Acid Drug Dev. by ST Crooke (1998)
  26. McKay, R. et al. Characterization of a potent and specific class of antisense oligonucleotide inhibitors of human PKC-alpha expression. J. Biol. Chem. 274, 1715–1722 (1999). (10.1074/jbc.274.3.1715) / J. Biol. Chem. by R McKay (1999)
  27. Ksontini, R. et al. Disparate roles for TNF-α and fas ligand in concanavalin A-induced hepatitis. J. Immunol. 160, 4082–4089 (1998). (10.4049/jimmunol.160.8.4082) / J. Immunol. by R Ksontini (1998)
  28. Watanabe, Y., Morita, M. & Akaike, T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24, 702–710 (1996). (10.1002/hep.510240338) / Hepatology by Y Watanabe (1996)
  29. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993). (10.1038/364806a0) / Nature by J Ogasawara (1993)
  30. Taieb, J., Mathurin, P., Poynard, T., Gougerot-Pocidalo, M.A. & Collet-Martin, S. Raised plasma-soluble fas and fas-ligand in alcoholic liver disease. Lancet 351, 1930–1931 (1998). (10.1016/S0140-6736(05)78614-1) / Lancet by J Taieb (1998)
  31. Ray, S.D., Mumaw, V.R., Ravindra, R., Fariss, R. & Fariss, M.W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J. Pharmacol. Exp. Ther. 279, 1470–1483 (1996). / J. Pharmacol. Exp. Ther. by SD Ray (1996)
  32. Blazka, M.E., Elwell, M.R., Holladay, S.D., Wilson, R.E. & Luster, M.I. Histology of acetaminophen-induced liver changes: role of interleukin 1α and tumor necrosis factor α. Toxicol. Pathol. 24, 181–189 (1996). (10.1177/019262339602400206) / Toxicol. Pathol. by ME Blazka (1996)
  33. Tiegs, G., Hentschel, J. & Wendel, A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196–203 (1992). (10.1172/JCI115836) / J. Clin. Invest. by G Tiegs (1992)
  34. Mochizuki, K. et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J. Hepatol. 24, 1–17 (1996). (10.1016/S0168-8278(96)80178-4) / J. Hepatol. by K Mochizuki (1996)
  35. Hayashi, N. & Mita, E. Fas system and apoptosis in viral hepatitis. J. Gastroenterol. Hepatol. 12, 9–10 (1997). / J. Gastroenterol. Hepatol. by N Hayashi (1997)
  36. Luo, K.-X et al. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J. Viral Hepatitis 4, 303–307 (1997). (10.1046/j.1365-2893.1997.00053.x) / J. Viral Hepatitis by K-X Luo (1997)
  37. Okazaki, M., Hino, K., Fujii, K., Kobayashi, N. & Okita, K. Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 41, 2453–2458 (1996). (10.1007/BF02100142) / Dig. Dis. Sci. by M Okazaki (1996)
  38. Sekine, K., Nishimaki, T., Suzuki, T. & Kasukawa, R. Expression of Fas antigen on hepatocytes in viral hepatitis patients. Fukushima J. Med. Sci. 43, 51–59 (1997). / Fukushima J. Med. Sci. by K Sekine (1997)
  39. Faubion, W.A. et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of fas. J. Clin. Invest. 103, 137–145 (1999). (10.1172/JCI4765) / J. Clin. Invest. by WA Faubion (1999)
  40. Strand, S. et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat. Med. 4, 588–593 (1998). (10.1038/nm0598-588) / Nat. Med. by S Strand (1998)
  41. Matsumura, R. et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjogren's syndrome. Clin. Exp. Rheumatol. 16, 561–568 (1998). / Clin. Exp. Rheumatol. by R Matsumura (1998)
  42. Afford, S.C. et al. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J. Exp. Med. 189, 441–446 (1999). (10.1084/jem.189.2.441) / J. Exp. Med. by SC Afford (1999)
  43. Seino, K.-I. et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315–1322 (1997). (10.1053/gast.1997.v113.pm9322527) / Gastroenterology by K-I Seino (1997)
  44. Tagawa, Y., Sekikawa, K. & Iwakure, Y. Suppression of concanavalin A-induced hepatitis in INF-r−/− mice, but not in TNF-a−/− mice. J. Immunol. 159, 1418–1428 (1997). (10.4049/jimmunol.159.3.1418) / J. Immunol. by Y Tagawa (1997)
  45. Baker, B.F. et al. 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272, 1994–2000 (1997). (10.1074/jbc.272.18.11994) / J. Biol. Chem. by BF Baker (1997)
  46. Hanecak, R. et al. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70, 5203–5212 (1996). (10.1128/JVI.70.8.5203-5212.1996) / J. Virol. by R Hanecak (1996)
  47. Geary, R.S. et al. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metab. Dispos. 25, 1272–1281 (1997). / Drug Metab. Dispos. by RS Geary (1997)
  48. Leeds, J.M., Graham, M.J., Truong, L. & Cummins, L.L. Quantitation of phosphorothioate oligonucleotides in human plasma. Anal. Biochem. 235, 36–43 (1996). (10.1006/abio.1996.0088) / Anal. Biochem. by JM Leeds (1996)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:35 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 3:17 p.m.)
Indexed 3 months, 1 week ago (May 18, 2025, 12:21 p.m.)
Issued 25 years, 1 month ago (Aug. 1, 2000)
Published 25 years, 1 month ago (Aug. 1, 2000)
Published Print 25 years, 1 month ago (Aug. 1, 2000)
Funders 0

None

@article{Zhang_2000, title={Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis}, volume={18}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/78475}, DOI={10.1038/78475}, number={8}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Zhang, Hong and Cook, Jesse and Nickel, Jeffrey and Yu, Rosie and Stecker, Kimberly and Myers, Kathleen and Dean, Nicholas M.}, year={2000}, month=aug, pages={862–867} }